The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial (427684)
ARTG Name
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
Product name
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
rozanolixizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information